Seizure-induced memory impairment is reduced by choline supplementation before or after status epilepticus

Gregory L Holmes1, Yili Yang, Zhao Liu

  • 1Department of Neurology, Center for Research in Pediatric Epilepsy, Harvard Medical School, Children's Hospital, Hunnewell 2, 300 Longwood Avenue, Boston, MA 02115, USA. gregory.holmes@tch.harvard.edu

Epilepsy Research
|February 2, 2002
PubMed

Insights

Choline supplementation before or after kainic acid-induced seizures improved memory in rats. This highlights choline

Area of Science:

  • Neuroscience
  • Nutritional Neuroscience
  • Neuroprotection

Background:

  • Status epilepticus can cause cognitive deficits.
  • Choline is vital for brain function and memory.
  • Previous studies suggest prenatal choline protects against pilocarpine-induced seizures.

Purpose of the Study:

  • To investigate the effects of pre- and postnatal choline supplementation on memory deficits induced by kainic acid (KA) status epilepticus.
  • To determine if choline supplementation can mitigate KA-induced cognitive impairment.

Main Methods:

  • Pregnant rats received normal, choline-supplemented, or choline-deficient diets.
  • Kainic acid (KA) was administered to induce status epilepticus at postnatal day 42 or 35.
  • Visual-spatial memory was assessed using the Morris water maze.
  • Hippocampal choline acetyltransferase activity was measured.

Main Results:

  • Rats receiving choline supplementation (pre- or postnatal) performed significantly better in the Morris water maze compared to control or choline-deficient groups.
  • Choline deficiency led to reduced hippocampal choline acetyltransferase activity.
  • Postnatal choline supplementation also improved memory performance after KA-induced seizures.

Conclusions:

  • Choline supplementation, administered either before or after kainic acid-induced status epilepticus, can protect against memory deficits.
  • Dietary choline plays a crucial role in mitigating cognitive impairments following seizures.

Related Concept Videos

Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types: